Could a simple injection slash opioid use after nose jobs?
NCT ID NCT06989866
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a numbing medicine called bupivacaine, injected after nose surgery, can reduce the need for strong opioid pain pills. Fifty adults having septorhinoplasty will receive either the numbing injection or a placebo. Researchers will count how many opioid pills they use and track their pain levels for a week.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Bupivacaine (a numbing medicine injected after surgery)
- What this could lead to
- If it works, this could offer a way to control pain after nose surgery with fewer opioid pills, reducing the risk of dependence.
- What could go wrong
- This is a small, early-phase trial with only 50 participants, so results may not apply to everyone. The numbing effect may not be strong enough to replace opioids for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2024
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients receiving a primary septorhinplasty at NMCP or Langley Air Force Base Exclusion Criteria: * History of alcohol abuse/dependence, mental health medications or opiate use disorder. Revision surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postoperative pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Naval Medical Center Portsmouth
Portsmouth, Virginia, 23708, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two nerve blocks go head to head for chest surgery pain
- Can a Nurse's confidence ease a Patient's postoperative pain?
- Antidepressant may double as pain reliever after gallbladder surgery
- Nerve blocks put to the test for breast surgery pain
- A Non-Opioid pain drug takes aim at Surgery's opioid problem
- Can a nerve block stop pain months after hysterectomy?